DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Dentsply Sirona and 3Shape are expanding their workflow integrations to enable dental professionals through DS Core and 3Shape Unite to use a scan-to-lab workflow or establish design and manufacturing protocols directly in their practice. CHARLOTTE, N.C.

Digital Dentistry: Dentsply Sirona and 3Shape expand their workflow integrations

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio

CHARLOTTE, N.C., Aug. 18, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2023 Global Healthcare Conference. Management is scheduled to participate in a fireside chat discussion on September 12, 2023, at 9:05 am ET.

Dentsply Sirona to Participate in the Baird 2023 Global Healthcare Conference

Insight Enterprises

First-of-its-kind Solution Addresses Sweeping Shifts in Dental Labor Market, Empowering Professionals and Practices Across the US; Appoints Industry Veteran as Chief Commercial Officer PHOENIX , Aug. 16, 2023 /PRNewswire/ -- Toothio , the on-demand dental staffing platform connecting qualified professionals with practices, today announced a $4 million seed round led by Craft Ventures with participation from Burst Capital, Moving Capital, Revere Partners, and Rho Capital Partners. This investment follows an initial backing from AZ Crown, founders of Insight Enterprises (Nasdaq: NSIT).

Toothio Raises $4M Led By Craft Ventures to Revolutionize Dental Staffing

SAN FRANCISCO , Aug. 14, 2023 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Dentsply Sirona, Inc. (NASDAQ: XRAY) concerning an alleged unlawful scheme to inflate revenue and earnings that resulted in an accounting restatement. Dentsply is one of the world's largest dental equipment manufacturers.

SHAREHOLDER ALERT: Dentsply Sirona, Inc. (XRAY) Officers and Directors Face Shareholder Investigation for Potential Wrongdoing Following Accounting Restatement

DENTSPLY SIRONA's (XRAY) Q2 revenues are driven by a rise in demand across key markets, especially in China. Improved pricing and restructuring initiatives boost earnings.

DENTSPLY SIRONA (XRAY) Beats on Q2 Earnings, Ups '23 EPS View

CHARLOTTE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2023.

Dentsply Sirona Reports Second Quarter 2023 Results

DENTSPLY SIRONA's (XRAY) second-quarter 2023 results are likely to reflect recovery in demand for consumable products, partially offset by lower sales in China due to volume-based procurement policy.

Is a Beat Likely for DENTSPLY SIRONA (XRAY) in Q2 Earnings?

Align Technology

Cooper Companies

Patterson Companies

West Pharmaceutical Services

Here we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, ALGN, COO, XRAY and PDCO.

5 Stocks to Buy From the Prospering Dental Supplies Industry

CHARLOTTE, N.C., July 12, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, August 3, 2023, at 8:30 am ET to review its second quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.

Dentsply Sirona to Host Second Quarter Conference Call on August 3rd

Here's Why You Should Invest in DENTSPLY SIRONA (XRAY) Stock

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and The Cooper Companies (COO). But which of these two stocks is more attractive to value investors?

XRAY vs. COO: Which Stock Is the Better Value Option?

After losing some value lately, a hammer chart pattern has been formed for Dentsply (XRAY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Here's Why Dentsply (XRAY) Is a Great 'Buy the Bottom' Stock Now

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock

The heavy selling pressure might have exhausted for Dentsply (XRAY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Down -7.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Dentsply (XRAY)

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Dentsply Sirona, Inc. (NASDAQ: XRAY) on behalf of long-term stockholders following a class action complaint that was filed against Dentsply on May 2, 2022 with a Class Period from June 9, 2021 to May 9, 2022. Our investigation concerns whether the board of directors of Dentsply have breached their fiduciary duties to the company. The complain.

DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating Dentsply Sirona, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

PHILADELPHIA , May 10, 2023 /PRNewswire/ -- Investor lawyers at the Rosca Scarlato law firm are investigating allegations of securities violations, corporate misconduct, and misrepresentations involving Dentsply Sirona and/or its directors and officers. The Rosca Scarlato attorneys are preparing to take action and seek compensation and/or other redress on behalf of any injured XRAY shareholders.

DENTSPLY SIRONA (NASDAQ: XRAY) SHAREHOLDER ALERT: POTENTIAL COMPENSATION CLAIMS: Rosca Scarlato Investor Lawyers Investigating

XRAY vs. COO: Which Stock Should Value Investors Buy Now?

DENTSPLY SIRONA, Inc. (NASDAQ:XRAY ) Q1 2023 Earnings Conference Call May 3, 2023 8:30 AM ET Company Participants Andrea Daley - VP, IR Simon Campion - CEO, President & Director Glenn Coleman - EVP & CFO Andreas Frank - EVP & Chief Business Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Jeffrey Johnson - Robert W. Baird & Co. Erin Wright - Morgan Stanley Daniel Clark - Bank of America Merrill Lynch Brandon Vazquez - William Blair & Company Jonathan Block - Stifel, Nicolaus & Company Jason Bednar - Piper Sandler & Co. Michael Petusky - Barrington Research Associates Rachel Vatnsdal - JPMorgan Chase & Co. Nathan Rich - Goldman Sachs Group Operator Good day, and thank you for standing by.

DENTSPLY SIRONA, Inc. (XRAY) Q1 2023 Earnings Call Transcript

DENTSPLY SIRONA's (XRAY) Q1 earnings and revenues decline year over year, driven by the unfavorable foreign currency movement and soft demand across all geographical segments.

DENTSPLY SIRONA (XRAY) Q1 Earnings & Revenues Beat Estimates

Although the revenue and EPS for Dentsply (XRAY) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Dentsply (XRAY) Q1 Earnings: A Look at Key Metrics

CHARLOTTE, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its financial results for the first quarter of 2023.

Dentsply Sirona Reports First Quarter 2023 Results

As part of its sustainability strategy "BEYOND: Taking action for a brighter world", Dentsply Sirona entered a three-way partnership with Smile Train and FDI World Dental Federation (FDI) in 2022 to improve quality and access to oral health - and specifically cleft care globally. CHARLOTTE, N.C.

Dentsply Sirona, FDI World Dental Federation and Smile Train deliver the first-ever global protocols for digital cleft treatment

CHARLOTTE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, May 3, 2023, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.

Dentsply Sirona to Host First Quarter Conference Call on May 3rd

First Republic

VeriSign

Boston Properties

Lumen Technologies

Norwegian Cruise Line

Newell Brands

There were some big changes made to the S&P 500 on March 17, with several well-known stocks getting reclassified. For instance, Target (NYSE: TGT ), Dollar General (NYDE: DG ) and Dollar Tree (NASDAQ: DLTR ) are now classified as consumer staples rather than consumer discretionary stocks.

News for DENTSPLY SIRONA Stock (XRAY)